U.S. Womens Health Devices Market Size, Share & COVID-19 Impact Analysis, By Application (General Health & Wellness, Cancers & Other Chronic Diseases, Reproductive Health, Pregnancy & Nursing Care, Pelvic & Uterine Health, and Others), By End-user (Hospitals & Clinics, Home Healthcare, and Others), and Country Forecast, 2023-2030

The U.S. women’s health devices market size was worth USD 19.85 billion in 2022 and is projected to grow at a CAGR of 9.6% during the forecast period.

In the U.S., there is a significant expenditure on women’s health due to substantial awareness regarding female cancer. In addition, numerous disease conditions are affecting women’s health in the U.S. The strong product preference to manage these disease conditions is promoting the U.S. women’s health devices market growth.

Furthermore, the engagement of key players to develop new women’s health products through robust R&D initiatives is expected to drive the market growth.

• For instance, in January 2023, F. Hoffmann-La Roche Ltd unveiled their robust focus on innovative technologies to improve patient outcomes. They supported the FemTechnology Summit, where new and innovative screening and tracking technologies revolutionizing care for women were discussed.

Similarly, various startup companies are engaging and presenting their approaches to improve women's health. Such positive initiatives are expected to propel the U.S. women’s health devices market expansion.

The COVID-19 pandemic negatively impacted the market growth. This was due to multiple disturbances in the supply chain and limited visits to healthcare professionals during the pandemic period.

LATEST TRENDS

Rising Investment by Major Players to Launch Advanced Women's Health Devices in the Market

The U.S. market has witnessed a strong demand for advanced healthcare facilities and products. The growing investments by various major and emerging players is strongly contributing to the market expansion. One of the advantages of these initiatives is that more convenient and cost-effective options are available, leading to more adoption of these devices.

In addition, these investments are expected to lead to the development of new women's health devices. For instance, in 2023, the New York Healthcare Innovation reported that the investment in women's health in the New York metro area was USD 540 million in 2021.

DRIVING FACTORS

Surge in Prevalence of Diseases Pertaining to Women's Health to Drive the Market Growth

Over the past few years, there has been a significant rise in the prevalence of women health diseases, increasing advancements in diagnostic technology, and growing awareness for preventive care in women. Some common women’s health diseases include breast cancer, cervical cancer, menopause, and pregnancy issues. This dramatic increase in prevalence has resulted in a large number of patients suffering from disabling and long-term conditions that have a significant impact on a patient’s day-to-day quality of life and a significant impact on their mortality.

• For instance, according to statistics published by the American Cancer Society, Inc., in 2023, it is estimated that there will be approximately 13,960 cervical cancer diagnosed cases in the U.S.

Due to the high prevalence of these diseases, there is a high demand for various health devices. In addition, this has prompted many medical device companies to participate in research and development (R&D) efforts to develop efficient devices for diagnosing, treating, and managing these diseases. The growing demand for these products due to the rising prevalence of various diseases is expected to promote strong growth in the coming years.

According to an article published by John Wiley & Sons, Inc., in 2022, the number of estimated cases of vagina and other genital cancers in the U.S. was 8,870.

RESTRAINING FACTORS

Side Effects Associated with Devices May Hinder the Market Expansion

Despite the intense need for women's healthcare, several limiting factors of these products are projected to hamper the U.S. market growth in the upcoming years.

Several side effects associated with women's health products are significantly limiting the market's growth prospects. Some of the possible adverse effects of these products, including breast pump devices, that women can experience are reduced milk supply, delay in the mother's recovery after childbirth, nipple and breast tissue damage, and engorgement. Similarly, intrauterine devices (IUDs) also cause multiple side effects in women. Such harmful effects associated with these devices are anticipated to restrict the market expansion in the U.S.

SEGMENTATION

By Application Analysis

By application, the U.S. market is divided into general health & wellness, cancer & other chronic diseases, reproductive health, pregnancy & nursing care, pelvic & uterine health, and others.

The cancer & other chronic diseases segment held the largest U.S. women’s health devices market share in 2022. A significant rise in the number of cancer cases in women is leading to an intensive need for efficient health devices. Such a scenario is expected to drive the growth of the segment during the forecast period.

• As per statistics published by the American Cancer Society in 2023, breast cancer is one of the most common cancers in women, except for skin cancers in the U.S.  In 2023, it is estimated that 297,790 cases of invasive breast cancer are expected to be diagnosed in women.

By End-user Analysis

Based on end user, this market is segmented into hospitals & clinics, home healthcare, and others.

The hospitals & clinics segment held a major share in 2022. The growth of this segment is attributed to the large patient base in these end-users settings for the diagnosis and treatment of several women’s conditions, including various types of cancer. Furthermore, a significant focus of key players to expand for the presence of its products in end users such as hospital and clinics through strategic activities is expected to promote the segmental growth.

• In August 2021, Unified Women’s Healthcare and Oak HC/FT acquired Women’s Health USA for an undisclosed amount. Through this acquisition, Unified and WHUSA represented the leading physician practice management company dedicated solely to women in the U.S.

KEY INDUSTRY PLAYERS

Several players in the U.S. women's health devices market, ranging from small to large, have diverse product portfolios and broad application areas. Currently, the competitive landscape of the market is dominated by F. Hoffman-La Roche Ltd. This is mainly due to the diagnostics portfolio, in which the company has several products that address female health issues. Similarly, Boston Scientific Corporation is another strong player with advanced pelvic health medical devices.

The other prominent players include CooperSurgical Inc., Coloplast A/S, and Hologic Inc. The growing initiatives, such as product innovations and strategic activities, contribute to these players' market dominance.

• In December 2022, CooperSurgical Inc. partnered with Ostro to educate consumers about Paragard. The Paragard (intrauterine copper contraceptive) is a U.S. FDA-approved intrauterine device that prevents pregnancy for up to 10 years.

LIST OF KEY COMPANIES PROFILED:

• Coloplast A/S (Denmark)


• Hologic Inc. (U.S.)


• Boston Scientific Corporation (U.S.)


• ALLERGAN (AbbVie, Inc.) (U.S.)


• BD (Becton, Dickinson, and Company) (U.S.)


• F. Hoffmann-La Roche Ltd (Switzerland)


• CooperSurgical Inc. (The Cooper Companies, Inc.) (U.S.)


• Caldera Medical (U.S.)


• Reckitt Benckiser Group PLC (U.K.)

KEY INDUSTRY DEVELOPMENTS: 

• September 2022 – Innovative Health Diagnostic launched a new direct-to-consumer test, the Anti-Mullerian Hormone (AMH).


• August 2022 – Mira launched Ovum Wand for its POC test to predict menopause and monitor fertility status for women over the age of 35. The solution would provide lab-accurate detection for follicle-stimulating hormone (FSH).


• March 2022 – Boditech Med, a global leader in POC testing, established its operations in North America. The company began seeking approvals from the U.S. FDA for diagnostic solutions such as cardiac, cancer, hormone, infectious disease, and other therapeutic areas.

REPORT COVERAGE

The market research report provides a comprehensive analysis of the market, including the prevalence of the key disease indications, an overview of start-ups and innovation in the industry, key industry developments, product launches, and the impact of the COVID-19 pandemic on the U.S. market. In addition to the women’s health devices market analysis, the report provides insights into market trends and key strategies of market players in women's health devices. The report also includes several factors that have favored the market growth in recent years.

Report Scope & Segmentation